For patients
IL-17 inhibitors
secukinumab, ixekizumab, bimekizumab, anti-IL-17
Are you a clinician? See the clinical version of this page.
The short versionIL-17 inhibitors (used for psoriatic arthritis and axial spondyloarthritis) may be continued in pregnancy if needed to control your disease, based on a shared decision, since the data are still limited. Breastfeeding data are more limited, so discuss timing with your team.
- These are options for psoriatic arthritis or axial spondyloarthritis when needed in pregnancy.
Through your pregnancy journey
Use if needed
Before pregnancy
May be continued if needed for disease control; discuss with your team.
Use if needed
First trimester
Used if needed for disease control.
Use if needed
Second & third trimester
Used if needed for disease control.
Use if needed
Breastfeeding
Breastfeeding data are limited; large antibodies transfer minimally into milk. Discuss with your team.
Continue
For fathers-to-be
Considered compatible for fathers-to-be.
iThis page helps you prepare a conversation with your care team. It does not replace individual medical advice. Always confirm your own plan with your rheumatology and pregnancy team.
!
When to call your team
- Do not stop or start these medicines without your team.
- Tell your baby's team which biologics you took in pregnancy.